These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 20552942)

  • 1. Patents to "treat me", no patents to "test me": an analysis of the 2009 Senate inquiry into gene patents.
    Triffett D
    J Law Med; 2010 May; 17(5):800-6. PubMed ID: 20552942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human genome, property of all: opportunities under the ALRC inquiry into gene patenting and human health.
    Hinojosa JP
    Syd Law Rev; 2004 Sep; 26(3):447-55. PubMed ID: 16523584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing time for gene patents.
    Nature; 2010 Apr; 464(7291):957. PubMed ID: 20393513
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACOG. Committee opinion: number 277, November 2002. Patients, medicine and the interests of patients: applying general principles to gene patenting.
    Comittee on Ethics, Comittee on Genetics, The American College of Obstetrician and Gynecologists
    Obstet Gynecol; 2002 Nov; 100(5 Pt 1):1051-6. PubMed ID: 12434779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
    Schilling SH
    Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing innovation and access to healthcare through the patent system--an Australian perspective.
    Nicol D
    Community Genet; 2005; 8(4):228-34. PubMed ID: 16244477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [No to patents for genetic diagnostics].
    Lundsteen C
    Ugeskr Laeger; 2000 Jun; 162(25):3620-1. PubMed ID: 11016292
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diffuse rules on patent protection of genes. Scientists risk retroactive payment requirements].
    Orn P
    Lakartidningen; 2000 Nov; 97(46):5285-6. PubMed ID: 11116864
    [No Abstract]   [Full Text] [Related]  

  • 11. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 12. "Sufficiency" for living organism inventions under the Patents Act 1990 (Cth).
    Lawson C
    J Law Med; 2004 Feb; 11(3):373-81. PubMed ID: 15018213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene patents, health care policy and licensing schemes.
    Caulfield T; von Tigerstrom B
    Trends Biotechnol; 2006 Jun; 24(6):251-4. PubMed ID: 16621074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do patents impede the provision of genetic tests in Australia?
    Nicol D; Liddicoat J
    Aust Health Rev; 2013 Jun; 37(3):281-5. PubMed ID: 23702081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patents. U.S. appeals court hears gene patent arguments.
    Marshall E
    Science; 2012 Jul; 337(6092):277-8. PubMed ID: 22822118
    [No Abstract]   [Full Text] [Related]  

  • 16. American College of Medical Genetics position statement on gene patents and accessibility of gene testing.
    Genet Med; 1999; 1(5):237. PubMed ID: 11256680
    [No Abstract]   [Full Text] [Related]  

  • 17. Data disclosure crucial after DNA patent verdict.
    de Costa A
    Science; 2013 Aug; 341(6149):959. PubMed ID: 23990544
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.
    Merz JF
    Clin Chem; 1999 Mar; 45(3):324-30. PubMed ID: 10053032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA.
    Vines T; Crow K; Faunce T
    J Law Med; 2012 Dec; 20(2):280-94. PubMed ID: 23431847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are human genes patentable?
    Sampson MJ
    Hastings Cent Rep; 2000; 30(4):4-5. PubMed ID: 10971884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.